$ZD

Ziff Davis Q2 Earnings Call Highlights

Ziff Davis (NASDAQ:ZD) reported Q2 call highlights. Advertising and performance-marketing revenue fell 6% YoY and subscription and licensing revenue was flat. Other revenue rose over 2x, up about $3.7M, mainly from Semantic Labs. Cash was $1.6B and long-term investments $100M. The company accelerated buybacks, repurchasing 2.6M shares for $121.5M, and expects Q3 revenue to rise sequentially but fall YoY.

Original reporting
Published Aug 9, 2026, 4:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 9, 2026, 4:54 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ziff Davis Q2 Earnings Call Highlights — source image
Decision brief

The 30-second read

$ZDNeutralMed
01

Why it matters

Key decision inputs are the company’s Q3 and Q4 directional guidance, the pace of share repurchases, and management’s explanation for search traffic pressure and advertising softness in specific brands (IGN, MedPage Today).

02

Market read

Traders can update positioning based on management’s Q3 revenue decline expectation (YoY) despite sequential growth, margin modest improvement, and continued buyback acceleration.

03

What to watch

The guidance is directional but lacks quantified revenue/EBITDA margin ranges; the magnitude of sequential improvement and the extent of MedPage and IGN ad stabilization could drive the stock more than the headline revenue trends.

Relevance 7/10Novelty 6/10Timing: post-earnings call, pre-market positioning for Q3/Q4 expectations

Background

The piece summarizes Ziff Davis Q2 earnings call themes across revenue segments, capital allocation, and AI product-development strategy.

Company-level read

Ticker impact

$ZDNeutralMedium confidence
Context

Ziff Davis guided Q3 revenue to rise sequentially but decline low- to mid-single digits YoY, with modest adjusted EBITDA margin improvement.

Expected impact

Near-term trading likely hinges on how investors weigh search traffic pressure and segment revenue declines versus margin support and buyback pace.

Evidence & confidence

The article provides forward-looking Q3 and Q4 directional guidance, detailed buyback deployment, and specific drivers (search AI overviews share, IGN ad weakness, MedPage customer budget shifts).

Market effects

Digital media and performance marketing peers may face similar search-distribution and ad-spend shifts toward lower-cost AI platforms.

No specific regional impact beyond US-listed media and ad-tech sentiment.

Limited direct global read-through; mostly company-specific guidance and AI-development process changes.

Counterpoint

Investors may be underestimating the durability of affiliate and social monetization as search traffic mix shifts toward AI overviews.

Key entities

  • Ziff Davis

    Digital media and internet company operating PCMag, IGN, and performance marketing platforms; provided Q2 highlights and Q3/Q4 directional guidance.

  • OpenAI

    Referenced in ongoing litigation tied to Ziff Davis’ AI content licensing stance.

  • Google AI Overviews

    Management cited rising share of relevant queries showing Google AI Overviews, indicating distribution pressure on traditional search.

Related articles

$ZDMed

ZIFF DAVIS, INC. (ZD): Results of Operations and Financial Condition

ZIFF DAVIS, INC. (ZD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 zd20260630pressrelease.htm EX-99.1 Document Exhibit 99.1 Ziff Davis Reports Second Quarter 2026 Financial Results NEW YORK, NY -- August 6, 2026 -- Ziff Davis, Inc. (NASDAQ: ZD) (“Ziff Davis” or “the Company”) today reported unaudited financial results for the second qu

$ZDLow

ZIFF DAVIS, INC. (ZD): Completion of Acquisition or Disposition of Assets

ZIFF DAVIS, INC. (ZD) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-10.1 2 exhibit101ziffdavis-connec.htm EX-10.1 Document EXHIBIT 10.1 June 15, 2026 Reference is made to the Credit Agreement, dated as of April 7, 2021 (as the same has been amended, and as the same may be amended, restated, supplemented or otherwise modified from time to time,

$SGIMed

Somnigroup International Q2 Earnings Call Highlights

Somnigroup (NYSE:SGI) reported Q2 updates on Mattress Firm store refresh and brand-wall programs, and plans to expand Kingsdown to nearly 800 stores after a 3-month pilot. North America adjusted gross margin rose to 61.8% and operating margin to 26.7%. Full-year adjusted EPS guidance was reaffirmed at $2.85 to $3.15, with sales guidance around $7.6B midpoint. It expects Leggett & Platt deal to close before Q3 end.

$SHOMedAI 8/10

Sunstone Hotel Investors Q2 Earnings Call Highlights

Sunstone Hotel Investors (NYSE:SHO) reported Q2 call highlights including RevPAR growth in several markets, with San Francisco up 16% and Wine Country resorts up 5% RevPAR. Andaz Miami Beach posted $2.8M EBITDA on 72% occupancy. Sunstone sold Hyatt Regency San Francisco for nearly 20x trailing EBITDA and repurchased about $40M common shares at $9.24. 2026 outlook: RevPAR +7% to +9% to $239-$244, adjusted EBITDAre $245M-$255M, FFO/share $0.93-$0.98.

$ROADMed

Construction Partners, Inc. Q3 2026 Earnings Call Summary

Construction Partners, Inc. reported Q3 2026 results driven by cost pass-through amid energy inflation and unusually wet weather. Management said Sunbelt demand tied to AI data centers and acquisitions support growth. Fiscal 2026 guidance was raised to over 30% revenue and margin growth, with 75% to 85% EBITDA to operating cash flow and leverage targeting 2.5x.

$RXOMed

RXO Q2 Earnings Call Highlights

RXO (NYSE:RXO) reported Q2 spot freight rising to 42% of truckload volume, up 900 bps sequentially and 1,500 bps YoY. Truckload gross profit per load rose 11% sequentially, while brokerage margin fell 70 bps to 10.7% on higher fuel. Complementary services revenue rose 7% to $488M. Q3 adjusted EBITDA guidance is $35M to $45M; adjusted free cash flow was -$42M in Q2.